Business
- Vaxcyte’s Broad-Spectrum Pneumococcal Vaccines Poised For Market Dominance By 2027
08 Sep, 2024 - As Interest From Families Wanes, Pediatricians Scale Back on COVID Shots
08 Sep, 2024 - High Mpox Vaccine Price to Pose Key Hurdle in Africa Order Talks
08 Sep, 2024 - Pharmaceutical Technology 2024 Excellence Awards Honor Botanical Solution Inc. (BSI) as Dual Category Award Winner
06 Sep, 2024 - Mpox: Is Africa ready to enter the vaccine race?
06 Sep, 2024 - A look at flu vaccine manufacturing and supply in the post-pandemic era
06 Sep, 2024 - Pneumococcal Vaccine Market Research 2024-2030: Prevnar 13, VAXNEUVANCE, PNEUMOSIL Size, Share & Trends Analysis
06 Sep, 2024 - Bavarian Nordic reacts to call for fair price for mpox vaccine
06 Sep, 2024 - Hilleman and Bharat Biotech launch oral cholera vaccine in India
05 Sep, 2024 - Bavarian Nordic stock slides on Moderna mpox vaccine study (NASDAQ:MRNA)
05 Sep, 2024 - Cancer Vaccines Industry Research Report 2024: Market Poised for Exponential Growth with a Projected Value of $6.7 Billion by 2032
05 Sep, 2024 - Recombinant Vaccines Market Size to Hit USD 32.83 Billion by 2032, Driven by Rising Global Incidence of Infectious Diseases
05 Sep, 2024 - First delivery of mpox vaccine doses from the Commission arrive today in the Democratic Republic of the Congo
05 Sep, 2024 - New Covid vaccine: Independent pharmacies report delays as Pfizer and Moderna doses roll out
05 Sep, 2024 - Vaccine Adjuvants Strategic Research Report 2024
05 Sep, 2024 - Vaxcyte’s Vaccine Progress Leads To $1.3 Billion Fundraising Plan
05 Sep, 2024 - $6.1 Bn Vaccine Contract Manufacturing Market by Vaccine Type, Workflow, Application, and Region 2024-2032
05 Sep, 2024 - Valneva shares hold strong with buy rating on Lyme vaccine data
04 Sep, 2024 - Aspen mulls mpox vaccine production (Pink Current Info:APNHF)
03 Sep, 2024 - Vaxcyte’s Pneumococcal Vaccine Results Propel Shares Over 30%
03 Sep, 2024 - Catalysing vaccines and biologics manufacturing in Africa
03 Sep, 2024 - Pneumococcal Vaccine Market Estimated to be Worth USD 14.78 Billion by 2034, at 5.2% CAGR: Prophecy Market Insights
03 Sep, 2024 - Adult Vaccine Market Size and Global Forecast Report 2024-2032
03 Sep, 2024 - The Largest Import Markets for Vaccines: Key Statistics and Trends
03 Sep, 2024 - Indonesian e-bike, vaccine makers seek to expand in Africa
03 Sep, 2024 - Moderna Korea to supply updated Covid-19 vaccine through Boryung Biopharma
03 Sep, 2024 - Analyzing economic effect on mRNA vaccine inventory management with redistribution policy
03 Sep, 2024 - Updated COVID vaccines are now available
03 Sep, 2024
0 Comments